| Literature DB >> 28965767 |
Maria Kleppe1, Matthew H Spitzer2, Sheng Li3, Corinne E Hill1, Lauren Dong1, Efthymia Papalexi1, Sofie De Groote1, Robert L Bowman1, Matthew Keller1, Priya Koppikar1, Franck T Rapaport4, Julie Teruya-Feldstein5, Jorge Gandara6, Christopher E Mason6, Garry P Nolan7, Ross L Levine8.
Abstract
JAK1 is a critical effector of pro-inflammatory cytokine signaling and plays important roles in immune function, while abnormal JAK1 activity has been linked to immunological and neoplastic diseases. Specific functions of JAK1 in the context of hematopoiesis, and specifically within hematopoietic stem cells (HSCs), have not clearly been delineated. Here, we show that conditional Jak1 loss in HSCs reduces their self-renewal and markedly alters lymphoid/myeloid differentiation in vivo. Jak1-deficient HSCs exhibit decreased competitiveness in vivo and are unable to rescue hematopoiesis in the setting of myelosuppression. They exhibit increased quiescence, an inability to enter the cell cycle in response to hematopoietic stress, and a marked reduction in cytokine sensing, including in response to type I interferons and IL-3. Moreover, Jak1 loss is not fully rescued by expression of a constitutively active Jak2 allele. Together, these data highlight an essential role for Jak1 in HSC homeostasis and stress responses.Entities:
Keywords: Jak1; cytokine signaling; hematopoietic stem cells; stress hematopoiesis
Mesh:
Substances:
Year: 2017 PMID: 28965767 PMCID: PMC5847260 DOI: 10.1016/j.stem.2017.08.011
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 24.633